U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,837.70
    +0.90 (+0.05%)
     
  • Silver

    24.22
    +0.13 (+0.55%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.1819%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.79
    -0.49 (-2.30%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.1088%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.2696%)
     
  • BTC-USD

    18,993.00
    +98.48 (+0.52%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Robert A. Sherman Speaks at MassBio Town Hall on the Impact of 2020 Presidential Election Results on the Biopharma Industry

·3 min read

Robert A. Sherman, senior counsel in the Boston office of global law firm Greenberg Traurig, LLP and former U.S. Ambassador to Portugal, was a featured speaker at the Massachusetts Biotechnology Council (MassBio) Town Hall on Thursday, Nov. 5, 2020.

BOSTON, Nov. 9, 2020 /PRNewswire-PRWeb/ -- Robert A. Sherman, senior counsel in the Boston office of global law firm Greenberg Traurig, LLP and former U.S. Ambassador to Portugal, was a featured speaker at the Massachusetts Biotechnology Council (MassBio) Town Hall on Thursday, Nov. 5, 2020. The Town Hall focused on the election results of the 2020 United States presidential election and what they mean for the biopharma industry.

The Town Hall panel included:

  • Robert K. Coughlin (President & CEO, Massachusetts Biotechnology Council)

  • Jennifer Nason (Senior Director of Communications, Massachusetts Biotechnology Council)

  • Tamar Thompson (Vice President of U.S. Government Affairs, Alexion Pharmaceuticals, Inc.)

Sherman focuses his practice on government and regulatory investigations and litigation, internal corporate investigations - with an emphasis on Foreign Corrupt Practices Act (FCPA) compliance - as well as consumer protection and class action defense. He has broad experience representing clients in complex, high profile cases including those that have generated significant media attention.

From 2014-2017, Sherman served as the United States Ambassador to Portugal, having been nominated by President Barack Obama and unanimously confirmed by the United States Senate. As Ambassador, he focused heavily on bilateral economic development and international security issues, such as cybersecurity, refugees, narcoterrorism and NATO. In recognition of Sherman's work in the country, Portuguese President Marcelo Rebelo de Sousa decorated him with the Grand Cross of the Order of Prince Henry the Navigator in March 2017.

About Greenberg Traurig's Life Sciences & Medical Technology Group: Greenberg Traurig's Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group's attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig's Boston Office: Established in 1999, Greenberg Traurig's Boston office is home to approximately 75 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, financial services, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of helping clients in complex legal matters and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2,200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 3.0 Certified. Web: http://www.gtlaw.com

Media Contact

Elaine Walker, Greenberg Traurig, LLP, +1 305 579 0832, walkere@gtlaw.com

Twitter

SOURCE Greenberg Traurig, LLP